PAI
Palo Alto Investors Portfolio holdings
AUM $470M
1-Year Return
2.57%
This Quarter Return
+44.94%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.82B
AUM Growth
+$315M
(+21%)
Cap. Flow
-$136M
Cap. Flow
% of AUM
-7.48%
Top 10 Holdings %
Top 10 Hldgs %
68.81%
Holding
39
New
2
Increased
2
Reduced
21
Closed
2
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$3.5M |
| 2 |
Amicus Therapeutics
FOLD
|
+$2.44M |
| 3 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$1.44M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$1.28M |
Top Sells
| 1 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
+$35.1M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$15.9M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$15.4M |
| 4 |
United Therapeutics
UTHR
|
+$11.9M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
+$11.6M |
Sector Composition
| 1 | Healthcare | 84.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
BioMarin Pharmaceuticals
BMRN
$10.2B
| $171M | 9.41% |
2,021,136
-188,368
| -9% | -$15.9M |
|
2
Insmed
INSM
$30.3B
| $164M | 9% |
6,848,760
-390,889
| -5% | -$9.33M |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $151M | 8.32% |
6,145,945
-208,714
| -3% | -$5.13M |
|
4
STAAR Surgical
STAA
$1.37B
| $133M | 7.32% |
3,778,938
-111,755
| -3% | -$3.93M |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| $125M | 6.9% |
5,923,195
-261,125
| -4% | -$5.53M |
|
|
6
United Therapeutics
UTHR
$18B
| $114M | 6.25% |
1,288,902
-135,499
| -10% | -$11.9M |
|
|
AIMT
7
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $113M | 6.23% |
3,380,441
-91,299
| -3% | -$3.06M |
|
|
ABMD
8
DELISTED
Abiomed Inc
ABMD
| $96.2M | 5.3% |
564,168
-90,260
| -14% | -$15.4M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $95M | 5.23% |
878,100
-79,850
| -8% | -$8.64M |
|
10
Karyopharm Therapeutics
KPTI
$54.3M
| $88.1M | 4.85% |
306,333
-16,477
| -5% | -$4.74M |
|
|
11
Acadia Pharmaceuticals
ACAD
$4.16B
| $81.5M | 4.49% |
1,905,374
-271,303
| -12% | -$11.6M |
|
|
WMGI
12
DELISTED
Wright Medical Group Inc
WMGI
| $75.1M | 4.13% |
2,463,055
-31,200
| -1% | -$951K |
|
13
Vanda Pharmaceuticals
VNDA
$259M
| $74.3M | 4.09% |
4,525,476
-55,700
| -1% | -$914K |
|
|
14
Amicus Therapeutics
FOLD
$2.47B
| $72.2M | 3.98% |
7,413,920
+251,000
| +4% | +$2.44M |
|
|
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
| $52.7M | 2.9% |
5,056,286
+335,542
| +7% | +$3.5M |
|
|
SAGE
16
DELISTED
Sage Therapeutics
SAGE
| $47.2M | 2.6% |
653,594
-27,300
| -4% | -$1.97M |
|
|
AMAG
17
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $37.1M | 2.04% |
3,044,374
-34,500
| -1% | -$420K |
|
18
Align Technology
ALGN
$9.56B
| $35.6M | 1.96% |
127,505
-20,000
| -14% | -$5.58M |
|
|
MNTA
19
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $33.3M | 1.83% |
1,685,372
-71,750
| -4% | -$1.42M |
|
20
Prothena Corp
PRTA
$439M
| $15.7M | 0.87% |
992,749
-11,700
| -1% | -$185K |
|
21
Puma Biotechnology
PBYI
$234M
| $11.8M | 0.65% |
1,349,180
-56,500
| -4% | -$494K |
|
22
Rigel Pharmaceuticals
RIGL
$627M
| $7.58M | 0.42% |
354,255
-4,480
| -1% | -$95.9K |
|
|
DRNA
23
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.31M | 0.4% |
331,813
| – | – |
|
|
KLDO
24
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $3.96M | 0.22% |
787,999
| – | – |
|
25
Gilead Sciences
GILD
$138B
| $2.55M | 0.14% |
39,300
| – | – |
|